Antonios Papanicolau‐Sengos

This paper introduces EXPAND, an interpretable AI model that predicts breast cancer subtypes and survival using nuclear features, achieving performance comparable to black-box models.

ENLIGHT predicts patient response to targeted and immunotherapies using tumor transcriptomes without prior treatment response data, showing better accuracy than existing transcriptomics-based signatures.